Analyst Price Targets — WALD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 2, 2026 10:45 am | Susan Anderson | Canaccord Genuity | $3.00 | $1.83 | StreetInsider | Waldencast Acquisition Corp. (WALD) PT Raised to $3 at Canaccord |
| January 14, 2026 11:28 am | — | Jefferies | $2.00 | $1.62 | TheFly | Waldencast assumed with a Buy at Jefferies |
| November 25, 2025 10:28 am | — | Telsey Advisory | $3.00 | $2.88 | TheFly | Waldencast downgraded to Market Perform from Outperform at Telsey Advisory |
| November 25, 2025 10:15 am | Stephanie Wissink | Jefferies | $3.50 | $2.88 | StreetInsider | Waldencast Acquisition Corp. (WALD) PT Lowered to $3.50 at Jefferies |
| April 22, 2025 1:16 pm | — | Industrial Alliance Securities | $5.00 | $2.93 | TheFly | Waldencast initiated with a Buy at Alliance Global Partners |
| March 20, 2025 1:59 pm | — | Telsey Advisory | $5.00 | $3.13 | TheFly | Waldencast price target lowered to $5 from $6 at Telsey Advisory |
| December 3, 2024 9:04 pm | Linda Bolton Weiser | D.A. Davidson | $7.50 | $3.23 | StreetInsider | Waldencast Acquisition Corp. (WALD) PT Raised to $7.50 at DA Davidson |
| May 28, 2024 5:07 am | Linda Bolton Weiser | D.A. Davidson | $6.50 | $4.18 | StreetInsider | Waldencast Acquisition Corp. (WALD) PT Lowered to $6.50 at DA Davidson |
| November 17, 2022 6:16 am | — | D.A. Davidson | $15.50 | $9.99 | Benzinga | DA Davidson Maintains Buy on Waldencast, Raises Price Target to $15.5 |
| September 8, 2022 4:25 pm | Linda Bolton Weiser | D.A. Davidson | $12.00 | $8.60 | TheFly | Waldencast Acquisition initiated with a Buy at DA Davidson |
Latest News for WALD
LONDON, June 15, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced that the U.S. Food and Drug Administration (“FDA”) has approved Obagi® saypha® ChIQ™ injectable hyaluronic acid (“HA”) gel, the latest addition to the Obagi® injectable portfolio under the Obagi Medical brand. This approval builds on the launch of…
LONDON, June 01, 2026 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or “the Company”) today announced that it has entered into a definitive agreement to sell its Obagi Medical dermatological skincare and aesthetics business (“Obagi Medical”) to Bridgepoint, one of the world's leading mid-market investors, in a transaction valued at up to $460 million, marking a significant step in Waldencast's…
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation A multi-city pop-up introducing consumers to the future of skincare and longevity innovation
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for WALD.
U.S. House Trading
No House trades found for WALD.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.